• Welcome to SynInnova
  • +1 780 485 2962
  • sales@syninnova.com
  • Welcome Guest
×

Tetomilast

Our Main Products

Shipping

World wide shipping

24 X 7 service

online service for 24 x 7

Latest Products

Updated Product Catalog

New Products New product

SI-5167

Tetomilast, >98% (HPLC)

CAS No. : [145739-56-6]

MDL No. : MFCD00936868

Synonyms : OPC6535

IUPAC Name : 6-(2-(3,4-Diethoxyphenyl)thiazol-4-yl)picolinic acid

Price And Availability
Pack SizePrice in USDAdd To Shopping CartAvailabilityShipping Status
5MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
10MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
25MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
50MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
100MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
250MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
500MGRequest A Quote
Back Order  Estimated to ship on 04 October 2026
1GRequest A Quote
Back Order  Estimated to ship on 04 October 2026
We accept
Note: Tetomilastis not in stock but can be available through custom synthesis. The estimated lead-time is 4-6 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You!
Chemical Properites
Mol. Formula :
C19H18N2O4S
Mol. Weight :
370.42
Appearance :
Solid
Melting Point :
Not available
For Laboratory research use only, not for drug, household or other uses.

Applications : Tetomilast is a novel thiazole phosphodiesterase-4 (PDE-4) inhibitor, which may prove useful in both the treatment of inflammatory bowel disease (IBD) and chronic obstructive pulmonary disease (COPD). The pharmacological profile of Tetomilast revealed an IC50 value of 380 nM, which is weaker than those of Roflumilast and Cilomilast. Moreover, it has a long half-life (approximately 24h) and high bioavailability (nearly 100%), which are better than those of Roflumilast and Cilomilast. These data support Tetomilast as a suitable once-daily orally administered candidate.

References : Mulhall A. M. et al.: Expert Opin. Invest. Drugs 24, 1597-1611, 2015; Ti H. et al.: J. Med. Chem., 62(13), 5944-5978, 2019.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

Recently Viewed Products

Related Products